A LITTLE LIGHTBULB MOMENT
Cardiovascular and renal pharmacology
ARBs: block angiotensin II receptor
Sign in to bookmark this concept and add private notes →
The bouncer blocks the angiotensin II door
The idea behind the cue
Angiotensin receptor blockers prevent angiotensin II from binding AT1 receptors. This reduces vasoconstriction and aldosterone effects while generally avoiding the bradykinin-mediated cough seen with ACE inhibitors.
Practice this flashcard →Make it memorable
Short & simple
The bouncer blocks the angiotensin II door
Acronym
AAC — Airborne Alpacas Cackle.
Story
A villain named Angio II rushes for the club door labeled AT1. A bouncer in sunglasses blocks the entrance, so the club stays calm and roomy. The air is quiet because the bouncer did not spill bradykinin.
Connect the pieces
- A (Airborne) → AT1: ARBs block the AT1 receptor where angiotensin II normally acts.
- A (Alpacas) → Ang II: Angiotensin II cannot bind its main receptor, so vasoconstriction and aldosterone effects fall.
- C (Cackle) → Cough: Unlike ACE inhibitors, ARBs usually avoid the bradykinin-mediated cough.
- Airborne · AT1: ARBs block the AT1 receptor where angiotensin II normally acts.
- Alpacas · Ang II: Angiotensin II cannot bind its main receptor, so vasoconstriction and aldosterone effects fall.
- Cackle · Cough: Unlike ACE inhibitors, ARBs usually avoid the bradykinin-mediated cough.
Know the limits
This targets AT1 receptors; it is not the same as ACE inhibition and does not increase bradykinin.
Further reading · OpenStax Pharmacology for Nurses · foundational mechanisms ↗Check your understanding
What is the primary action of an ARB?
A. Blocks angiotensin II at the AT1 receptor
B. Blocks conversion of angiotensin I to angiotensin II
C. Inhibits sodium reabsorption in the proximal tubule via carbonic anhydrase
D. Blocks calcium entry into vascular smooth muscle
Reveal explanation
Blocks angiotensin II at the AT1 receptor
ARBs antagonize the angiotensin II AT1 receptor. ACE inhibitors block enzyme conversion, carbonic anhydrase inhibitors work in the proximal tubule, and calcium channel blockers block calcium influx.